|
1
|
Sakurai T, Amemiya A, Ishii M, Matsuzaki
I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP,
Wilson S, et al: Orexins and orexin receptors: a family of
hypothalamic neuropeptides and G protein-coupled receptors that
regulate feeding behavior. Cell. 92:573–585. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kukkonen JP, Holmqvist T, Ammoun S and
Akerman KE: Functions of the orexinergic/hypocretinergic system. Am
J Physiol Cell Physiol. 283:C1567–C1591. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Lecea L, Kilduff TS, Peyron C, Gao X,
Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT,
Bartlett FS II, et al: The hypocretins: hypothalamus-specific
peptides with neuroexcitatory activity. Proc Natl Acad Sci USA.
95:322–327. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsuki T and Sakurai T: Orexins and
orexin receptors: from molecules to integrative physiology. Results
Probl Cell Differ. 46:27–55. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gestreau C, Bévengut M and Dutschmann M:
The dual role of the orexin/hypocretin system in modulating
wakefulness and respiratory drive. Curr Opin Pulm Med. 14:512–518.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aston-Jones G, Smith RJ, Sartor GC,
Moorman DE, Massi L, Tahsili-Fahadan P and Richardson KA: Lateral
hypothalamic orexin/hypocretin neurons: a role in reward-seeking
and addiction. Brain Res. 1314:74–90. 2010. View Article : Google Scholar
|
|
7
|
Kodadek T and Cai D: Chemistry and biology
of orexin signaling. Mol Biosyst. 6:1366–1375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nambu T, Sakurai T, Mizukami K, Hosoya Y,
Yanagisawa M and Goto K: Distribution of orexin neurons in the
adult rat brain. Brain Res. 827:243–260. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Voisin T, Rouet-Benzineb P, Reuter N and
Laburthe M: Orexins and their receptors: structural aspects and
role in peripheral tissues. Cell Mol Life Sci. 60:72–87. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rouet-Benzineb P, Rouyer-Fessard C, Jarry
A, Avondo V, Pouzet C, Yanagisawa M, Laboisse C, Laburthe M and
Voisin T: Orexins acting at native OX(1) receptor in colon cancer
and neuroblastoma cells or at recombinant OX(1) receptor suppress
cell growth by inducing apoptosis. J Biol Chem. 279:45875–45886.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Voisin T, Firar AE, Avondo V and Laburthe
M: Orexin-induced apoptosis: the key role of the
seven-transmembrane domain orexin type 2 receptor. Endocrinology.
147:4977–4984. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spinazzi R, Rucinski M, Neri G,
Malendowicz LK and Nussdorfer GG: Prepro Orexin and orexin
receptors are expressed in cortisol-secreting adrenocortical
adenomas, and orexins stimulate in vitro cortisol secretion and
growth of tumor cells. J Clin Endocrinol Metab. 90:3544–3549. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Biegańska K, Sokołowska P, Jöhren O and
Zawilska JB: Orexin A suppresses the growth of rat C6 glioma cells
via a caspase-dependent mechanism. J Mol Neurosci. 48:706–712.
2012. View Article : Google Scholar
|
|
14
|
Martin JL and Baxter RC: Expression of
insulin-like growth factor binding protein-2 by MCF-7 breast cancer
cells is regulated through the phosphatidylinositol
3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology.
148:2532–2541. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chow S, Minden MD and Hedley DW:
Constitutive phosphorylation of the S6 ribosomal protein via mTOR
and ERK signaling in the peripheral blasts of acute leukemia
patients. Exp Hematol. 34:1183–1191. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bessard A, Frémin C, Ezan F, Coutant A and
Baffet G: MEK/ERK-dependent uPAR expression is required for
motility via phosphorylation of P70S6K in human hepatocarcinoma
cells. J Cell Physiol. 212:526–536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Papadimitrakopoulou V and Adjei AA: The
Akt/mTOR and mitogen-activated protein kinase pathways in lung
cancer therapy. J Thorac Oncol. 1:749–751. 2006. View Article : Google Scholar
|
|
18
|
Chan SM, Weng AP, Tibshirani R, Aster JC
and Utz PJ: Notch signals positively regulate activity of the mTOR
pathway in T-cell acute lymphoblastic leukemia. Blood. 110:278–286.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han Z, Wu K, Shen H, Li C, Han S, Hong L,
Shi Y, Liu N, Guo C, Xue Y, et al: Akt1/protein kinase B alpha is
involved in gastric cancer progression and cell proliferation. Dig
Dis Sci. 53:1801–1810. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Downward J: Mechanisms and consequences of
activation of protein kinase B/Akt. Curr Opin Cell Biol.
10:262–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim JH, Go HY, Jin DH, Kim HP, Hong MH,
Chung WY, Park JH, Jang JB, Jung H, Shin YC, et al: Inhibition of
the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of
Rhus verniciflua Stokes-induced apoptosis via a mitochondrial
pathway in AGS gastric cancer cell lines. Cancer Lett. 265:197–205.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu M, Li CM, Chen ZF, Ji R, Guo QH, Li Q,
Zhang HL and Zhou YN: Celecoxib regulates apoptosis and autophagy
via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer
cells. Int J Mol Med. 33:1451–14588. 2014.PubMed/NCBI
|
|
23
|
Walczak K, Turski WA and Rajtar G:
Kynurenic acid inhibits colon cancer proliferation in vitro:
effects on signaling pathways. Amino Acids. 46:2393–2401. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim MS, Yoon CY, Jang PG, Park YJ, Shin
CS, Park HS, Ryu JW, Pak YK, Park JY, Lee KU, et al: The mitogenic
and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol
Endocrinol. 18:2291–2301. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gagnon A, Dods P, Roustan-Delatour N, Chen
CS and Sorisky A: Phosphatidylinositol-3,4,5-trisphosphate is
required for insulin-like growth factor 1-mediated survival of
3T3-L1 preadipocytes. Endocrinology. 142:205–212. 2001.PubMed/NCBI
|
|
26
|
Skrzypski M, Kaczmarek P, Le TT,
Wojciechowicz T, Pruszyńska-Oszmalek E, Szczepankiewicz D, Sassek
M, Arafat A, Wiedenmann B, Nowak KW and Strowski MZ: Effects of
orexin A on proliferation, survival, apoptosis and differentiation
of 3T3-L1 preadipocytes into mature adipocytes. FEBS Lett.
586:4157–4164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Johnson CE, Huang YY, Parrish AB, Smith
MI, Vaughn AE, Zhang Q, Wright KM, Van Dyke T, Wechsler-Reya RJ,
Kornbluth S and Deshmukh M: Differential Apaf-1 levels allow
cytochrome c to induce apoptosis in brain tumors but not in normal
neural tissues. Proc Natl Acad Sci USA. 104:20820–20825. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ammoun S, Lindholm D, Woolz H, Akerman KE
and Kukkonen JP: G-protein-coupled OX1 orexin/hcrtr-1 hypocretin
receptors induce caspase-dependent and -independent cell death
through p38-/stress-activated protein kinase. J Biol Chem.
281:834–842. 2006. View Article : Google Scholar
|
|
30
|
Tang J, Chen J, Ramanjaneya M, Punn A,
Conner AC and Randeva HS: The signalling profile of recombinant
human orexin-2 receptor. Cell Signal. 20:1651–1661. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Darker JG, Porter RA, Eggleston DS, Smart
D, Brough SJ, Sabido-David C and Jerman JC: Structure-activity
analysis of truncated orexin-A analogues at the orexin-1 receptor.
Bioorg Med Chem Lett. 11:737–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rizzuto R, Pinton P, Ferrari D, Chami M,
Szabadkai G, Magalhães PJ, Di Virgilio F and Pozzan T: Calcium and
apoptosis: facts and hypotheses. Oncogene. 22:8619–8627. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maoret JJ, Anini Y, Rouyer-Fessard C,
Gully D and Laburthe M: Neurotensin and a non-peptide neurotensin
receptor antagonist control human colon cancer cell growth in cell
culture and in cells xenografted into nude mice. Int J Cancer.
80:448–454. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Darmoul D, Gratio V, Devaud H, Lehy T and
Laburthe M: Aberrant expression and activation of the thrombin
receptor protease-activated receptor-1 induces cell proliferation
and motility in human colon cancer cells. Am J Pathol.
162:1503–1513. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Darmoul D, Gratio V, Devaud H and Laburthe
M: Protease-activated receptor 2 in colon cancer: trypsin-induced
MAPK phosphorylation and cell proliferation are mediated by
epidermal growth factor receptor transactivation. J Biol Chem.
279:20927–20934. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Keely SJ, Uribe JM and Barrett KE:
Carbachol stimulates transactivation of epidermal growth factor
receptor and mitogen-activated protein kinase in T84 cells.
Implications for carbachol-stimulated chloride secretion. J Biol
Chem. 273:27111–27117. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shaw RJ and Cantley LC: Ras, PI(3)K and
mTOR signalling controls tumour cell growth. Nature. 441:424–430.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Y, Liu J, Liu X, Xing K, Wang Y, Li F
and Yao L: Resveratrol-induced cell inhibition of growth and
apoptosis in MCF7 human breast cancer cells are associated with
modulation of phosphorylated Akt and caspase-9. Appl Biochem
Biotechnol. 135:181–192. 2006. View Article : Google Scholar
|
|
40
|
Zhang G, Li M, Zhu X, Bai Y and Yang C:
Knockdown of akt sensitizes osteosarcoma cells to apoptosis induced
by Cisplatin treatment. Int J Mol Sci. 12:2994–3005. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song L, Xiong H, Li J, Liao W, Wang L, Wu
J and Li M: Sphingosine kinase-1 enhances resistance to apoptosis
through activation of PI3K/Akt/NF-kappaB pathway in human non-small
cell lung cancer. Clin Cancer Res. 17:1839–1849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhu Z, Sun H, Ma G, Wang Z, Li E and Liu Y
and Liu Y: Bufalin induces lung cancer cell apoptosis via the
inhibition of pi3k/akt pathway. Int J Mol Sci. 13:2025–2035. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu Q, Dong HW, Sun WG, Liu M, Ibla JC,
Liu LX, Parry JW, Han XH, Li MS and Liu JR: Apoptosis initiation of
β-ionone in SGC-7901 gastric carcinoma cancer cells via a PI3K-AKT
pathway. Arch Toxicol. 87:481–490. 2013. View Article : Google Scholar
|
|
44
|
Creagh EM, Conroy H and Martin SJ:
Caspase-activation pathways in apoptosis and immunity. Immunol Rev.
193:10–21. 2003. View Article : Google Scholar : PubMed/NCBI
|
